Our study conducted a comprehensive assessment of REV1, explored the role of REV1 in various cancers as a prognostic biomarker and further highlight a potential function whereby REV1 may regulate the sensitivity of tumor cells to specific drugs. This evidence concerns the gene REV1 and cancer.